Endo News Roundup: CGM & Metformin Use

February 6, 2017

New studies review updated guidelines for metformin use, an examination of all-cause mortality in T2DM, and continuous glucose monitoring for T1DM.

Highlights of three new studies in diabetes include how using continuous glucose monitoring improves hemoglobin A1c (HbA1c) levels compared with self-monitoring blood glucose levels for adults with T1DM who are using multiple daily insulin injections; T2DM patients who use metformin can improve key clinical outcomes if they have moderate to severe chronic kidney disease (CKD), congestive heart failure (CHF), or chronic liver disease (CLD) with hepatic impairment; patients with T2DM should receive first-line therapy with metformin when medication is needed to improve high blood sugar, according to  updated guidelines from the American College of Physicians (ACP).